Barely Significant
← all excerpts

Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer.

J Clin Endocrinol Metab · 2016 · PMC5095235 · PMID 27548104

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

marginally significantP = .06so close (0.05 < p ≤ 0.1)
In a multivariate model, percentage change in tumor size at the first assessment was a marginally significant positive predictor for PFS ( P = .06).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.